3O'Donoghue M, Kenney P, Oestreicher E, et al. Usefulness of aminoterminal Pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department [ J ]. Am J Cardiol,2007,100 ( 9 ) : 1 336-1 340.
4Regitz V, Shug AL, Fleck E. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart disases [ J ]. Am J Cardiol, 1990,65 (11) :755-769.
5Calvani M,Reda E, Arrigoni-Martelli E. Regulation by earuitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions [ J ]. Basic Res Cardiol,2000,95 (20) :75-83.
6Rizxos I. Three year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration [ J ]. Am Heart J,20(10, 139(2 Pt 3) : 120-123.
7Che-Ping Cheng, Zakariya K, Satoshi M, et al. Protective effects of L- carnitine on left ventricular and myocyte dysfunction after short-term oral alcohol administration in rat. [ J ]. Circulation,2006,114 : Ⅱ3-Ⅱ4.
8Parthenakis FI,Patrianakos AP,Haritakis CN.et al. NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy [ J]. Eur J Heart Fail, 2008,10 (5) : 475-481.
9Bettencourt P, Azevedo A, Pimenta J et al. N-terminal-Pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [ J ]. Circulation,2004,110 ( 15 ) : 2 168-2 174.
10Troehu JN, Mital S ,Zhang X ,et al. Preservation of NO production by statins in the treatment of hean failure. Cardiovasc Res,2003, 60(9) :250-258.
